Header Logo

Connection

SYELING LAI to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications SYELING LAI has written about Drug Resistance, Neoplasm.
SYELING LAI
Connection Strength
0.117
Drug Resistance, Neoplasm
  1. HIV-related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to Nivolumab. Clin Lymphoma Myeloma Leuk. 2018 02; 18(2):e143-e146.
    View in: PubMed
    Score: 0.105
  2. Cyclooxygenase-2 protein reduces tamoxifen and N-(4-hydroxyphenyl)retinamide inhibitory effects in breast cancer cells. Lab Invest. 2005 Nov; 85(11):1357-67.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.